Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Orphan, Tropical Diseases Need Better Drug Development Guidance - Senate

Executive Summary

A floor amendment to the Senate Agriculture/FDA appropriations bill would push FDA toward streamlining the development and regulation of drugs to treat rare diseases and neglected diseases in the developing world

You may also be interested in...



Increased FDA China Inspections Backed By House Panel, While Purse Strings Pulled Still Tighter

Funds for the Reagan-Udall Foundation must come from the FDA commissioner’s office account, under successful amendment from Rep. DeLauro.

FDA Funding Bill In Senate Gives Generic Drugs More, But Commissioner Less

A Senate Appropriations Committee-approved funding package would provide the Center for Drug Evaluation and Research with $5 million more than requested by the Obama administration

FDA Funding Bill In Senate Gives Generic Drugs More, But Commissioner Less

A Senate Appropriations Committee-approved funding package would provide the Center for Drug Evaluation and Research with $5 million more than requested by the Obama administration

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051388

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel